{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:02:31Z","timestamp":1776304951527,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bpobgyn.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T13:52:18Z","timestamp":1401976338000},"page":"903-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The contraception needs of the perimenopausal woman"],"prefix":"10.1016","volume":"28","author":[{"given":"Sarah M.R.","family":"Hardman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailsa E.","family":"Gebbie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.05.006_bib1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(13)62035-8","article-title":"Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National surveys of sexual attitudes and lifestyles (Natsal)","volume":"382","author":"Mercer","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib2","article-title":"Conceptions in England and Wales 2011","author":"Office of National Statistics","year":"2013","journal-title":"ONS Stat Bull"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib5","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organisation","year":"2010"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib7","first-page":"CD003989","article-title":"20\u00a0\u03bcg versus >20\u00a0\u03bcg estrogen combined oral contraceptives for contraception","volume":"8","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/jfprhc-2013-100605","article-title":"Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24\/4 regimen","volume":"39","author":"Shulman","year":"2013","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1783\/147118909788707878","article-title":"Qlaira: a 'natural' change of direction","volume":"35","author":"Mansour","year":"2009","journal-title":"J\u00a0Fam Plann Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib10","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1479-828X.1991.tb02769.x","article-title":"Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1701-2163(16)34151-2","article-title":"A\u00a0Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia","volume":"31","author":"Endrikat","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib13","doi-asserted-by":"crossref","first-page":"f3251","DOI":"10.1136\/bmj.f3251","article-title":"Managing unscheduled bleeding in non-pregnant premenopausal women","volume":"346","author":"Lumsden","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.contraception.2011.11.011","article-title":"Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest","volume":"86","author":"Fraser","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/13625187.2012.713535","article-title":"The contraceptive vaginal ring, NuvaRing\u00ae, a decade after its introduction","volume":"17","author":"Roumen","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00042192-200107000-00011","article-title":"A\u00a0scheme of combined oral contraceptives for women more than 40 years old","volume":"8","author":"Bl\u00fcmel","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","article-title":"Combined hormonal contraception and bone health: a systematic review","volume":"73","author":"Martins","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib18","first-page":"CD006033","article-title":"Steroidal contraceptives: effect on bone fractures in women","volume":"7","author":"Lopez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib19","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"8","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, 2576 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1586\/era.11.38","article-title":"Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis","volume":"11","author":"Cibula","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib24","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2007.11.1179","article-title":"Oral contraceptives and breast cancer risk in the international BRCA1\/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group","volume":"25","author":"Brohet","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J\u00a0Thromb Haemo"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib28","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib29","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib30","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib31","series-title":"UK medical eligibility criteria for contraceptive use","author":"Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists","year":"2009"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e32833c07bc","article-title":"Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women","volume":"17","author":"Oli\u00e9","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jth.12060","article-title":"The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy","volume":"11","author":"Roach","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib35","doi-asserted-by":"crossref","first-page":"d8059","DOI":"10.1136\/bmj.d8059","article-title":"Determinants of the decline in mortality from MI in England 2002\u20132010","volume":"344","author":"Smolina","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib36","unstructured":"Cancer Research UK; www.cancerresearchuk.org\/cancerinfo\/cancerstats\/types\/breast\/incidence\/#age figures [last accessed 10.05.14]."},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib38","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib39","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib40","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib41","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bpobgyn.2007.03.023","article-title":"Modern management of abnormal uterine bleeding: the levonorgestrel intrauterine system","volume":"21","author":"Mansour","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib44","series-title":"Clinical guidance: contraception for women aged over 40 years","author":"Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists","year":"2010"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib46","first-page":"CD002126","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","volume":"4","author":"Lethaby","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib47","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","volume":"2","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib48","first-page":"548","article-title":"Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis","volume":"41","author":"Lan","year":"2013","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2010.04148.x","article-title":"Hormone therapies and venous thromboembolism: where are we now?","volume":"9","author":"van Hylckama Vlieg","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1933719113503408","article-title":"Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits: systematic review of literature","volume":"21","author":"Gizzo","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs intramuscular DMPA: a 2 year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104\u00a0mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib54","first-page":"57","article-title":"Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers","volume":"35","author":"K\u00fc\u00e7\u00fck","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2014.05.006_bib55","first-page":"419","article-title":"Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer","volume":"41","author":"Kaunitz","year":"1996","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.2012.03298.x","article-title":"Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study","volume":"119","author":"Wilailak","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0010-7824(95)00215-V","article-title":"Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives","volume":"52","author":"Thomas","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/AOG.0b013e318283d1a1","article-title":"Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture","volume":"121","author":"Lanza","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.contraception.2012.04.009","article-title":"Hormonal contraception and bone metabolism: a systematic review","volume":"86","author":"Nappi","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00198-013-2429-z","article-title":"Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study","volume":"25","author":"Mori","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib61","unstructured":"FRAX: WHO fracture risk assessment tool; www.shef.ac.uk\/FRAX\/ [last accessed 09.05.14]."},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib62","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib63","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib64","first-page":"CD005214","article-title":"Depot medroxyprogesterone versus norethisterone enanthate for long-acting progestogenic contraception","volume":"3","author":"Draper","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib65","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-11-4064","article-title":"Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.1995.03520340055036","article-title":"Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies","volume":"273","author":"Skegg","year":"1995","journal-title":"JAMA"},{"issue":"Suppl.","key":"10.1016\/j.bpobgyn.2014.05.006_bib67","first-page":"113","article-title":"The effects of implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","article-title":"Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide","volume":"84","author":"Endrikat","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib69","first-page":"CD007541","article-title":"Progestin-only pills for contraception","volume":"11","author":"Grimes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib70","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/sti.2007.027847","article-title":"Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system","volume":"84","author":"Bodley-Tickell","year":"2008","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/0956462412472295","article-title":"Negative perceptions about condom use in a clinic population: comparisons by gender, race and age","volume":"24","author":"Crosby","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib72","first-page":"131","article-title":"Assessing menopausal status in women aged 40\u201349 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception","volume":"101","author":"Beksinska","year":"2011","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.bpobgyn.2014.05.006_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7196\/SAMJ.4224","article-title":"Incidence of ovulation in perimenopausal women before and during hormone replacement therapy","volume":"52","author":"Gebbie","year":"1995","journal-title":"Contraception"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:25:16Z","timestamp":1538569516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414001060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1521693414001060"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contraception needs of the perimenopausal woman","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}